On the scene at LHSC
LHSC’s new President and CEO announced
Ruthe Anne Conyngham, Chair of LHSC’s Board of Directors, announced on May 7 the appointment of Murray Glendining as LHSC’s new President and CEO, effective immediately. Glendining brings a wealth of experience to the role, having joined LHSC in June 2012 as Executive Vice President of Corporate Services and Clinical Support and also recently serving as LHSC’s Acting President and CEO.
Glendining brings over 35 years of experience in the public and private sectors and has a successful track record of working collaboratively with a variety of partners and stakeholders including governments, communities and other health service providers to strengthen and advance patient care objectives.
Prior to joining LHSC, Glendining spent 10 years at Hamilton Health Sciences (HHS) as Executive Vice President of Corporate Affairs, and for his last five years at HHS he was also Regional Chief Information Officer of the Niagara, Haldimand and Brant Local Health Integration Network (LHIN).
LHSC staff and physicians exceed United Way campaign goal for the second year in a row
For the second year in a row, LHSC has exceeded its goal for the annual LHSC United Way Campaign, this year raising $152,145 to support those in need in our community.
“Last year our staff and physicians showed an unprecedented level of support and awareness for the United Way, and we were confident that our campaign committee and United Way Champions would continue building on that momentum,” says LHSC President and CEO Murray Glendining. “We set an ambitious goal, and I am very pleased that together we have surpassed it.”
This year’s internal campaign theme was “Care Beyond Our Walls” to highlight the impact LHSC’s people can have within our community.
Oncology After-Care Program celebrates 10 years at Children’s Hospital
The Oncology After-Care Program at Children’s Hospital, London Health Sciences Centre (LHSC), celebrated its 10th anniversary in May. Launched in collaboration with the Pediatric Oncology Group of Ontario (POGO) in 2004, the program follows children with cancer from the time their condition is considered stabilized/in remission throughout the remainder of their lifetime.
Patients attend the multi-disciplinary clinic once a year for follow-up, with visits focusing on issues such as promotion of healthy lifestyle, screening for secondary cancers, as well as early detection of long-term side effects from treatments such as hormone changes, cardiac damage, and bone loss. They also receive psychosocial support as needed. Younger survivors, adolescents and young adults may all receive additional training, neuropsychological treatment and support when their disease and treatment have interfered with the achievement of their educational and career goals.
LHSC receives additional epilepsy monitoring beds
The Honourable Deb Matthews, Minister of Health and Long-Term Care and MPP for London North Centre, was on-site at University Hospital (UH) on Mar. 28 to announce funding for 21 new hospital beds for epilepsy patients across the province, including three at LHSC. This funding will create two new adult epilepsy monitoring beds at UH and one paediatric epilepsy monitoring bed that is already up and running at LHSC’s Children’s Hospital.
These new beds will build on LHSC’s current eight-bed monitoring unit, which is already the largest inpatient epilepsy monitoring unit in Canada. This unit is devoted to exploring both surgical options and other types of treatment for epilepsy patients. LHSC’s Epilepsy Program was established 36 years ago and cares for the patients of southwestern Ontario, as well as northern Ontario, the Ottawa region, and out-of-province patients. The team is interdisciplinary and highly skilled with an international reputation for excellence.